Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation

NCT01721967 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01721967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
May 31, 2016
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy